Cellular Origins is hosting a webinar on 9 September featuring engineers Bec Egan and Leo Steenson discussing robotics and automation in cell therapy manufacturing

Cell therapy manufacturing was never designed to scale. Cellular Origins is changing that. We enable the manufacture of cell therapies at commercial scale through a flexible, factory-led approach. Our platform, Constellation, combines mobile robotics and AI to orchestrate the movement of patient material, equipment, and processes across the entire facility, while integrating with your leading bioprocessing technologies. By replacing fixed, linear systems with modular, parallelisable design, we enable intelligent capacity planning, built-in redundancy, and seamless scale-up without process redesign. The result is lower risk, greater efficiency, increased flexibility, and a faster path to commercialisation. Trusted by global leaders, Cellular Origins is redefining how cell therapies are industrialised for widespread patient access.